Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2013-001221-13 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Aim:
Clinical RCT comparing functional results and recurrence rate following enzymatic treatment vs. needle aponeurotomy.
Materials and methods:
30° or more contracture of only one metacarpophalangeal (MCP) joint contracture of one of the three ulnar digits and less than 20° for the adjacent proximal interphalangeal (PIP) joint. Patients with primary disease of the hand. Total of 80 patients needed to detect difference of 13.5°.
1) Needle aponeurotomy 2) Clostridium Histolyticum treatment. Clinical follow ups 1,4 weeks, 16 weeks and 1,2 and 5 years. Functional outcome scores: URAM, Quick Dash, EQ5D, brief MHQ, VAS pain and VAS patient satisfaction. Total passive extension contracture reduction, recurrence rate and registration of complications.
Open surgery (fascieectomy) has traditionally been considered the gold standard of treatment for Dupytren´s disease (Dd) despite considerable risk of complications.
There is an increasing interest in Scandinavia in the treatment of Dd with Clostridium Histolyticum (Xiapex ®, Auxillium). However the enzyme is expensive and long-term effects are not well documented. More studies are needed to analyze both short and long term clinical outcome as well as cost-benefit analysis.
The treatment arm of Xiapex in this study follows the recommendation as by the producer.
The other treatment of Dd contracture in this study is needle fasiotomy/aponeurotomy. We use multiple perforation technigue with 26 G needle needle, with as little local anesthesia (xylocin w adrenaline) as needed during contionus extension of the finger untill successfully extended.
The two procedures leave little scar tissue lessening the challenges posed by the reoperations.
Recurrence rate of contracture following different treatments of Dupuytren's disease differs widely in the literature, and the rate is influenced by multiple factors.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Needle aponeurotomy | Active Comparator | percutaneous transection or pretendinous palmar dupytren cord |
|
| Xiapex | Active Comparator | Injection of 0.58 mg collagenase into pretendinous palmar dupytren cord |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Xiapex | Drug | Injection of collagenase of primary dupytren cord |
|
| Measure | Description | Time Frame |
|---|---|---|
| Reduction in Total Passive Extension Deficit | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Quick Dash (Disabilities of the shoulder and Hand) | 5 years | |
| EQ5D (Euroqol 5 Dimensions) | 5 years | |
| Brief MHQ (Michigan Hand Questionare) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Per-Henrik Randsborg, PhD | University Hospital, Akershus | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Akershus University Hospital | Oslo | Akershus | 1478 | Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004387 | Dupuytren Contracture |
| ID | Term |
|---|---|
| D005350 | Fibroma |
| D018218 | Neoplasms, Fibrous Tissue |
| D009372 | Neoplasms, Connective Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
Not provided
Not provided
| ID | Term |
|---|---|
| C570746 | xiapex |
| D003012 | Microbial Collagenase |
| ID | Term |
|---|---|
| D017364 | Collagenases |
| D008666 | Metalloendopeptidases |
| D010450 | Endopeptidases |
| D010447 | Peptide Hydrolases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Needle aponeurotomy | Procedure | 26 G needle multiple perforation tecqnique with local anesthetic |
|
|
| 5 years |
| URAM (Unité Rhumatologique des Affections de la Main) | 5 years |
| Jamar grip strength | 1,4,26 weeks and one year. |
| VAS (Visual analogue scale) pain | 0 is no pain, 10 maximum pain | 1,4,26 weeks and one year |
| VAS (Visual analogue sale) satisfaction | 0 is not satisfied, 10 maximum satisfied | 1,4,26 weeks. 1,2 and 5 years |
| Complications | AE,SAE,SUSAR | 1,4,weeks One year |
| Recurrence | def. 30 degrees of treated MCP joint, or 20 or more degrees of adjecent PIPJ | 1,4,26 weeks. 1,2 and 5 years |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D003286 | Contracture |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D006867 |
| Hydrolases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D045726 | Metalloproteases |